Evaluation of the Drug‑Drug Interaction Between Ramipril and Indapamide in Healthy Volunteers

1 1 1

What is this study about?

The study involves healthy volunteers and examines how two medicines that are normally used to treat hypertension interact when taken together. One medicine contains ramipril, which helps relax blood vessels, and the other contains indapamide, which helps the body get rid of excess fluid and also lowers blood pressure.

The purpose of the study is to determine whether taking the two medicines at the same time changes how each one is absorbed and processed in the body. Participants will receive a single dose of each medicine alone and then a single dose of both medicines together, with the order chosen at random, while fasting. Blood samples will be collected to assess the pharmacokinetic and bioavailability characteristics of the drugs, and any side effects will be recorded.

The study will evaluate the safety and tolerability of the medicines when used together and will involve only a short period of observation after the single dose administration.

Who Can Join the Study?

Who Cannot Join the Study?

Where you can join this trial?

Verified and Recommended Sites

No sites found in this category

Verified Sites

No sites found in this category

Other Sites

Site Name City Country Status
Cepha s.r.o. Plzen Czechia

Want to learn more about this study or check if you can participate? Contact us.

Trial status

Country Status Recruitment Start
Czechia Czechia
Not recruiting
15.08.2023

Trial locations

Investigated drugs:

Trial ID:
2023-505887-12-00
Trial Phase:
Human Pharmacology (Phase I) – Other

Other Trials to Consider

  • Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +17
  • A study to evaluate the effect of baxdrostat and dapagliflozin in reducing protein in the urine for patients with chronic kidney disease and high blood pressure

    Recruiting

    1 1
    Investigated drugs:
    Bulgaria Spain